# The influence of hypoxia on tissue regeneration in oral and maxillofacial surgery – a systematic review

**Authors:** Albrecht H. F. Gäde, Eik Schiegnitz, Alexander W. Eckert, Keyvan Sagheb, Bilal Al-Nawas, Johannes R. Kupka

PMC · DOI: 10.1007/s00784-026-06808-9 · Clinical Oral Investigations · 2026-03-16

## TL;DR

This review explores how low oxygen levels affect tissue regeneration in oral and maxillofacial surgery, focusing on strategies to improve healing outcomes.

## Contribution

The paper systematically reviews hypoxia's role and modulation strategies in oral and maxillofacial tissue regeneration.

## Key findings

- HIF-1α upregulation and hypoxic preconditioning can enhance bone formation and vascularization.
- Hyperbaric oxygen treatment consistently improves bone healing outcomes.
- HIF-1α also plays a role in osteoclast activation and bone resorption.

## Abstract

Hypoxia is an inevitable consequence of surgical interventions such as bone augmentation and soft tissue transplantation in oral and maxillofacial surgery. Cellular adaptation to hypoxic conditions critically influences regenerative processes, including osseointegration, angiogenesis and tissue integration. This systematic review investigated the effects of hypoxic conditions and hypoxia-regulating strategies on tissue regeneration, with the aim of identifying mechanisms to enhance clinical outcomes.

Following the PRISMA guidelines, a systematic search was performed in MEDLINE (via PubMed), Cochrane, and Web of Science up to 31st May 2025, including reference list and citation screening. The risk of bias was assessed according to the SYRCLE risk of bias tool.

Of 5790 studies, 9 met the inclusion criteria. These studies investigated various interventions, including gene therapy targeting hypoxia-inducible factor 1α (HIF-1α), oxygen-releasing biomaterial scaffolds, hyperbaric oxygen treatment and hypoxia preconditioning of bone marrow mesenchymal stem cells. Some studies showed enhanced bone formation and vascularization with HIF-1α upregulation or hypoxic preconditioning, while others highlighted HIF-1α’s role in osteoclast activation and bone resorption. Hyperbaric oxygen treatment consistently improved bone healing.

Current evidence highlights a complex interplay between hypoxia and regenerative outcomes in oral and maxillofacial surgery. Although modulation of HIF-1α and the hypoxic microenvironment hold promise, further research is needed to clarify optimal strategies for maximizing benefits and minimizing detrimental effects.

The ability to influence the HIF pathway in beneficial manner may be a cornerstone to unlocking the next generation of regenerative therapies in oral and maxillofacial surgery.

## Linked entities

- **Genes:** HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091]

## Full-text entities

- **Genes:** BMP2 (bone morphogenetic protein 2) [NCBI Gene 477162], VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, Ctsk (cathepsin K) [NCBI Gene 13038] {aka MMS10-Q, Ms10q, catK}, Arnt (aryl hydrocarbon receptor nuclear translocator) [NCBI Gene 11863] {aka D3Ertd557e, Drnt, ESTM42, Hif1b, bHLHe2, mKIAA4051}, Hif1an (hypoxia-inducible factor 1, alpha subunit inhibitor) [NCBI Gene 319594] {aka 2310046M24Rik, A830014H24Rik, FIH, FIH1}, Pecam1 (platelet/endothelial cell adhesion molecule 1) [NCBI Gene 18613] {aka Cd31, PECAM-1, Pecam}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 14173] {aka Fgf-2, Fgf2a, Fgfb, bFGF}, DCSTAMP (dendrocyte expressed seven transmembrane protein) [NCBI Gene 81501] {aka FIND, TM7SF4, hDC-STAMP}, Crebbp (CREB binding protein) [NCBI Gene 12914] {aka CBP, CBP/p300, KAT3A, p300/CBP}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 403802] {aka VEGF}, ANGPT1 (angiopoietin 1) [NCBI Gene 284] {aka AGP1, AGPT, AGPT-1, ANG1, HAE5}, Mul1 (mitochondrial ubiquitin ligase activator of NFKB 1) [NCBI Gene 68350] {aka 0610009K11Rik, Gide, Tnrip-1}, Flt1 (FMS-like tyrosine kinase 1) [NCBI Gene 14254] {aka Flt-1, VEGFR-1, VEGFR1, sFlt1}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, Ep300 (E1A binding protein p300) [NCBI Gene 328572] {aka A430090G16, A730011L11, KAT3B, p300, p300 HAT}, Dcstamp (dendrocyte expressed seven transmembrane protein) [NCBI Gene 75766] {aka 4833414I07Rik, DC-STAMP, FIND, Tm7sf4, mDC-STAMP}, Vhl (von Hippel-Lindau tumor suppressor) [NCBI Gene 22346] {aka Vhlh, pVHL}, Epas1 (endothelial PAS domain protein 1) [NCBI Gene 13819] {aka HIF-2alpha, HIF2A, HLF, HRF, MOP2, bHLHe73}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Fgf2 (fibroblast growth factor 2) [NCBI Gene 54250] {aka Fgf-2, Fgf2a, bFGF}, Pecam1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 29583] {aka CD31, Pecam}, Lrpap1 (low density lipoprotein receptor-related protein associated protein 1) [NCBI Gene 16976] {aka HBP44, RAP}, Hif3a (hypoxia inducible factor 3, alpha subunit) [NCBI Gene 53417] {aka Ipas, MOP7, NEPAS, bHLHe17}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 83785] {aka VEGF-A, VEGF111, VEGF164, VPF, Vegf}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Ldha (lactate dehydrogenase A) [NCBI Gene 16828] {aka Ldh1, Ldhm, l7R2}, Ctf1 (cardiotrophin 1) [NCBI Gene 13019] {aka CT-1}, HIF-1a [NCBI Gene 100009579], Angpt1 (angiopoietin 1) [NCBI Gene 11600] {aka 1110046O21Rik, Ang-1, Ang1}, Pfkl (phosphofructokinase, liver, B-type) [NCBI Gene 18641] {aka ATP-PFK, PFK-B, PFK-L}, Gck (glucokinase) [NCBI Gene 103988] {aka GLK, Gk, Gls006, HK4, HKIV, HXKP}, PGF (placental growth factor) [NCBI Gene 5228] {aka D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 18538], Bglap2 (bone gamma-carboxyglutamate protein 2) [NCBI Gene 12097] {aka BGP2, Bglap1, Bgp, Og2, mOC-B}, Pkm (pyruvate kinase, muscle) [NCBI Gene 18746] {aka Pk-2, Pk-3, Pk3, Pkm2}, Calca (calcitonin/calcitonin-related polypeptide, alpha) [NCBI Gene 12310] {aka CA, CGRP-1, CGRP1, Calc, Calc1, Cgrp}, Mki67 (antigen identified by monoclonal antibody Ki 67) [NCBI Gene 17345] {aka D630048A14Rik, Ki-67, Ki67}, FLT1 (fms related receptor tyrosine kinase 1) [NCBI Gene 2321] {aka FLT, FLT-1, VEGFR-1, VEGFR1}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Hif1a (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 29560] {aka HIF1-alpha, MOP1}, Pdlim3 (PDZ and LIM domain 3) [NCBI Gene 114108] {aka Actn2lp, Alp}, Pdc (phosducin) [NCBI Gene 20028] {aka Rpr-1, Rpr1}, Runx2 (runt related transcription factor 2) [NCBI Gene 12393] {aka AML3, CBF-alpha-1, Cbf, Cbfa-1, Cbfa1, LS3}, Cd40 (CD40 antigen) [NCBI Gene 21939] {aka Bp50, GP39, HIGM1, IGM, IMD3, T-BAM}, Runx2 (RUNX family transcription factor 2) [NCBI Gene 367218] {aka CBF-alpha-1, Cbfa1, OSF-2}
- **Diseases:** inflammation (MESH:D007249), Covid19 (MESH:D000086382), ischemia (MESH:D007511), diabetes (MESH:D003920), mandibular defects (MESH:D008338), BMD (MESH:D001851), wound dehiscence (MESH:D013529), hypoxic (MESH:D002534), osteoporosis (MESH:D010024), rheumatic arthritis (MESH:D012213), bone resorption (MESH:D001862), cancer (MESH:D009369), periodontal diseases (MESH:D010510), bone (MESH:D001847), metastases (MESH:D009362), alveolar bone defect (MESH:D016301), Hypoxia (MESH:D000860), ischemic (MESH:D002545), resorption (MESH:D014091)
- **Chemicals:** Dimethyloxalylglycine (MESH:C040947), pyruvate (MESH:D019289), CaO2 (MESH:C403632), CoCl2 (MESH:C018021), asparagine (MESH:D001216), O2 (MESH:D010100), Calcium-magnesium phosphate (MESH:C015335), lactic acid (MESH:D019344), PCL (MESH:C016240), phalloidin (MESH:D010590), CTX (-), Toluidine (MESH:D014052)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Mus musculus (house mouse, species) [taxon 10090], Canis lupus familiaris (dog, subspecies) [taxon 9615]
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12992415/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12992415/full.md

---
Source: https://tomesphere.com/paper/PMC12992415